GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » Piotroski F-Score

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Piotroski F-Score : 5 (As of May. 28, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Joincare Pharmaceutical Group Industry Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Joincare Pharmaceutical Group Industry Co's Piotroski F-Score or its related term are showing as below:

SHSE:600380' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Joincare Pharmaceutical Group Industry Co was 8. The lowest was 4. And the median was 6.


Joincare Pharmaceutical Group Industry Co Piotroski F-Score Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co Piotroski F-Score Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 6.00 7.00 5.00 6.00

Joincare Pharmaceutical Group Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 4.00 6.00 5.00

Competitive Comparison of Joincare Pharmaceutical Group Industry Co's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joincare Pharmaceutical Group Industry Co's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was 352.689 + 268.214 + 359.131 + 439.798 = ¥1,420 Mil.
Cash Flow from Operations was 1009.123 + 1202.644 + 1469.058 + 972.277 = ¥4,653 Mil.
Revenue was 4160.692 + 3931.516 + 3995.093 + 4339.814 = ¥16,427 Mil.
Gross Profit was 2600.737 + 2368.347 + 2533.216 + 2751.199 = ¥10,253 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(36193.051 + 36241.439 + 35769.669 + 36358.126 + 36462.147) / 5 = ¥36204.8864 Mil.
Total Assets at the begining of this year (Mar23) was ¥36,193 Mil.
Long-Term Debt & Capital Lease Obligation was ¥2,355 Mil.
Total Current Assets was ¥23,444 Mil.
Total Current Liabilities was ¥9,865 Mil.
Net Income was 340.731 + 325.293 + 376.215 + 462.746 = ¥1,505 Mil.

Revenue was 3907.602 + 4447.021 + 4130.786 + 4559.05 = ¥17,044 Mil.
Gross Profit was 2464.216 + 2910.662 + 2469.273 + 2845.584 = ¥10,690 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(32275.093 + 32181.513 + 34713.695 + 35735.43 + 36193.051) / 5 = ¥34219.7564 Mil.
Total Assets at the begining of last year (Mar22) was ¥32,275 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,687 Mil.
Total Current Assets was ¥23,548 Mil.
Total Current Liabilities was ¥9,395 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Joincare Pharmaceutical Group Industry Co's current Net Income (TTM) was 1,420. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Joincare Pharmaceutical Group Industry Co's current Cash Flow from Operations (TTM) was 4,653. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=1419.832/36193.051
=0.03922941

ROA (Last Year)=Net Income/Total Assets (Mar22)
=1504.985/32275.093
=0.04662992

Joincare Pharmaceutical Group Industry Co's return on assets of this year was 0.03922941. Joincare Pharmaceutical Group Industry Co's return on assets of last year was 0.04662992. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Joincare Pharmaceutical Group Industry Co's current Net Income (TTM) was 1,420. Joincare Pharmaceutical Group Industry Co's current Cash Flow from Operations (TTM) was 4,653. ==> 4,653 > 1,420 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=2354.699/36204.8864
=0.06503815

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=3686.649/34219.7564
=0.10773452

Joincare Pharmaceutical Group Industry Co's gearing of this year was 0.06503815. Joincare Pharmaceutical Group Industry Co's gearing of last year was 0.10773452. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=23443.751/9865.306
=2.37638356

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=23547.576/9395.021
=2.50638886

Joincare Pharmaceutical Group Industry Co's current ratio of this year was 2.37638356. Joincare Pharmaceutical Group Industry Co's current ratio of last year was 2.50638886. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Joincare Pharmaceutical Group Industry Co's number of shares in issue this year was 1867.508. Joincare Pharmaceutical Group Industry Co's number of shares in issue last year was 1929.717. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=10253.499/16427.115
=0.62418136

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=10689.735/17044.459
=0.62716775

Joincare Pharmaceutical Group Industry Co's gross margin of this year was 0.62418136. Joincare Pharmaceutical Group Industry Co's gross margin of last year was 0.62716775. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=16427.115/36193.051
=0.45387483

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=17044.459/32275.093
=0.52809945

Joincare Pharmaceutical Group Industry Co's asset turnover of this year was 0.45387483. Joincare Pharmaceutical Group Industry Co's asset turnover of last year was 0.52809945. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Joincare Pharmaceutical Group Industry Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Joincare Pharmaceutical Group Industry Co  (SHSE:600380) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Joincare Pharmaceutical Group Industry Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Traded in Other Exchanges
N/A
Address
No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Executives
Yu Xiong Directors, senior managers
Zhao Feng Guang senior management
Qiu Qing Feng Directors, senior managers
Tang Ling Zhi senior management
Lin Nan Qi Directors, senior managers
Cao Ping Wei Director
Feng Yan Fang Director
Zhong Shan senior management
Yang Dong Yun senior management
Peng Jin Hua Supervisors
Xie You Guo Supervisors
Guo Xiao Yun Supervisors
Su Qing Wen senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines